Pediatric IBS: an overview on pathophysiology, diagnosis and treatment

Ashish Chogle, Stijn Mintjens, Miguel Saps

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Irritable bowel syndrome (IBS) is a common disorder in children and adults. The pathogenesis and pathophysiology of IBS remains incompletely understood. The biopsychosocial model, which conceptualizes chronic pain as a dysregulation of the gut-brain-homeostasis with peripheral and central factors mutually influencing each other, is the most accepted framework to explain IBS. Twin and family aggregation studies suggest a genetic component that does not exclusively explain the higher prevalence of IBS in certain families. Social learning (environmental factors) and maladaptive coping predispose children to develop IBS with greater disability and more frequent medical consultations. Early-life events constitute an additional risk factor for the development of IBS and other functional gastrointestinal disorders (FGIDs). Children with a history of cow's milk protein hypersensitivity or abdominal surgeries have a higher prevalence of IBS and other FGIDs years later. IBS frequently follows an episode of acute gastrointestinal inflammation (infectious or non-infectious). This article discusses the importance, known pathophysiological mechanisms, clinical approach, and evidence-based therapeutic options for the management of IBS in children and adolescents.

Original languageEnglish
Pages (from-to)e76-82
JournalPediatric Research
Volume43
Issue number4
DOIs
Publication statusPublished - Apr 2014

Cite this

Chogle, Ashish ; Mintjens, Stijn ; Saps, Miguel. / Pediatric IBS : an overview on pathophysiology, diagnosis and treatment. In: Pediatric Research. 2014 ; Vol. 43, No. 4. pp. e76-82.
@article{0f7ceac3046642f4a6038ff78e987422,
title = "Pediatric IBS: an overview on pathophysiology, diagnosis and treatment",
abstract = "Irritable bowel syndrome (IBS) is a common disorder in children and adults. The pathogenesis and pathophysiology of IBS remains incompletely understood. The biopsychosocial model, which conceptualizes chronic pain as a dysregulation of the gut-brain-homeostasis with peripheral and central factors mutually influencing each other, is the most accepted framework to explain IBS. Twin and family aggregation studies suggest a genetic component that does not exclusively explain the higher prevalence of IBS in certain families. Social learning (environmental factors) and maladaptive coping predispose children to develop IBS with greater disability and more frequent medical consultations. Early-life events constitute an additional risk factor for the development of IBS and other functional gastrointestinal disorders (FGIDs). Children with a history of cow's milk protein hypersensitivity or abdominal surgeries have a higher prevalence of IBS and other FGIDs years later. IBS frequently follows an episode of acute gastrointestinal inflammation (infectious or non-infectious). This article discusses the importance, known pathophysiological mechanisms, clinical approach, and evidence-based therapeutic options for the management of IBS in children and adolescents.",
keywords = "Adolescent, Child, Cognitive Therapy, Diet Therapy, Humans, Hypnosis, Irritable Bowel Syndrome/diagnosis, Probiotics/therapeutic use",
author = "Ashish Chogle and Stijn Mintjens and Miguel Saps",
note = "Copyright 2014, SLACK Incorporated.",
year = "2014",
month = "4",
doi = "10.3928/00904481-20140325-08",
language = "English",
volume = "43",
pages = "e76--82",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Pediatric IBS : an overview on pathophysiology, diagnosis and treatment. / Chogle, Ashish; Mintjens, Stijn; Saps, Miguel.

In: Pediatric Research, Vol. 43, No. 4, 04.2014, p. e76-82.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Pediatric IBS

T2 - an overview on pathophysiology, diagnosis and treatment

AU - Chogle, Ashish

AU - Mintjens, Stijn

AU - Saps, Miguel

N1 - Copyright 2014, SLACK Incorporated.

PY - 2014/4

Y1 - 2014/4

N2 - Irritable bowel syndrome (IBS) is a common disorder in children and adults. The pathogenesis and pathophysiology of IBS remains incompletely understood. The biopsychosocial model, which conceptualizes chronic pain as a dysregulation of the gut-brain-homeostasis with peripheral and central factors mutually influencing each other, is the most accepted framework to explain IBS. Twin and family aggregation studies suggest a genetic component that does not exclusively explain the higher prevalence of IBS in certain families. Social learning (environmental factors) and maladaptive coping predispose children to develop IBS with greater disability and more frequent medical consultations. Early-life events constitute an additional risk factor for the development of IBS and other functional gastrointestinal disorders (FGIDs). Children with a history of cow's milk protein hypersensitivity or abdominal surgeries have a higher prevalence of IBS and other FGIDs years later. IBS frequently follows an episode of acute gastrointestinal inflammation (infectious or non-infectious). This article discusses the importance, known pathophysiological mechanisms, clinical approach, and evidence-based therapeutic options for the management of IBS in children and adolescents.

AB - Irritable bowel syndrome (IBS) is a common disorder in children and adults. The pathogenesis and pathophysiology of IBS remains incompletely understood. The biopsychosocial model, which conceptualizes chronic pain as a dysregulation of the gut-brain-homeostasis with peripheral and central factors mutually influencing each other, is the most accepted framework to explain IBS. Twin and family aggregation studies suggest a genetic component that does not exclusively explain the higher prevalence of IBS in certain families. Social learning (environmental factors) and maladaptive coping predispose children to develop IBS with greater disability and more frequent medical consultations. Early-life events constitute an additional risk factor for the development of IBS and other functional gastrointestinal disorders (FGIDs). Children with a history of cow's milk protein hypersensitivity or abdominal surgeries have a higher prevalence of IBS and other FGIDs years later. IBS frequently follows an episode of acute gastrointestinal inflammation (infectious or non-infectious). This article discusses the importance, known pathophysiological mechanisms, clinical approach, and evidence-based therapeutic options for the management of IBS in children and adolescents.

KW - Adolescent

KW - Child

KW - Cognitive Therapy

KW - Diet Therapy

KW - Humans

KW - Hypnosis

KW - Irritable Bowel Syndrome/diagnosis

KW - Probiotics/therapeutic use

U2 - 10.3928/00904481-20140325-08

DO - 10.3928/00904481-20140325-08

M3 - Review article

VL - 43

SP - e76-82

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 4

ER -